• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹水与上皮性卵巢癌:关于不同方面的重新评估

Ascites and epithelial ovarian cancers: a reappraisal with respect to different aspects.

作者信息

Ayhan A, Gultekin M, Taskiran C, Dursun P, Firat P, Bozdag G, Celik N Y, Yuce K

机构信息

Departments of Obstetrics and Gynecology and Pathology, Hacettepe University Faculty of Medicine, 06100 Ankara, Turkey.

出版信息

Int J Gynecol Cancer. 2007 Jan-Feb;17(1):68-75. doi: 10.1111/j.1525-1438.2006.00777.x.

DOI:10.1111/j.1525-1438.2006.00777.x
PMID:17291234
Abstract

Ascites is a common finding in patients with epithelial ovarian cancer (EOC). Clinico-pathologic correlations with respect to the presence of ascites, positive cytology and prognostic role of ascites, and the impact of ascitic volumes were not previously studied extensively. A total of 372 patients with EOC were retrospectively evaluated with respect to presence and amount of ascites, cytologic findings, and survival. Two groups were compared by using Chi-square, Student's t and Mann-Whitney U, binary logistic regression, Kaplan Meier and Cox-regression analysis tests, where appropriate. Omental metastasis (P < 0.001; OR: 3.21, 95% CI = 1.945-5.297) and mean number of metastatic lymph nodes (P= 0.008; OR: 1.063, 95% CI = 1.016-1.112) were significantly related with presence of ascites. Evaluation of ascitic volume at different thresholds revealed lymphatic-omental metastasis, and also the disease stage to be significantly different among patient groups at lower threshold values and the positive cytology and high-grade diseases at higher threshold values. In conclusion, presence of ascites correlates with both the intraperitoneal and also the retroperitoneal tumor spread. Amount of ascites has different correlations with the clinico-pathologic factors depending on the thresholds chosen. At lower volumes, lymphatic and omental metastasis seems to correlate with the development of ascites. Once ascites develops, tumor grade seems to be important for larger ascites volumes. Neither the presence of ascites or its volume nor the cytologic positivity was an independent predictor of survival.

摘要

腹水是上皮性卵巢癌(EOC)患者的常见表现。此前尚未广泛研究腹水的存在、阳性细胞学结果及腹水的预后作用,以及腹水量的影响与临床病理之间的相关性。对372例EOC患者的腹水存在情况、腹水量、细胞学检查结果及生存率进行了回顾性评估。在适当情况下,采用卡方检验、学生t检验、曼-惠特尼U检验、二元逻辑回归、Kaplan-Meier检验和Cox回归分析对两组进行比较。大网膜转移(P < 0.001;OR:3.21,95%CI = 1.945 - 5.297)和转移淋巴结的平均数量(P = 0.008;OR:1.063,95%CI = 1.016 - 1.112)与腹水的存在显著相关。对不同阈值下的腹水量进行评估发现,在较低阈值时,患者组间的淋巴管-大网膜转移及疾病分期存在显著差异,在较高阈值时,阳性细胞学结果及高级别疾病存在显著差异。总之,腹水的存在与腹膜内及腹膜后肿瘤扩散均相关。根据所选阈值不同,腹水量与临床病理因素有不同的相关性。腹水量较低时,淋巴管和大网膜转移似乎与腹水的形成相关。一旦腹水形成,肿瘤分级对于较大腹水量似乎很重要。腹水的存在与否、腹水量及细胞学阳性结果均不是生存的独立预测因素。

相似文献

1
Ascites and epithelial ovarian cancers: a reappraisal with respect to different aspects.腹水与上皮性卵巢癌:关于不同方面的重新评估
Int J Gynecol Cancer. 2007 Jan-Feb;17(1):68-75. doi: 10.1111/j.1525-1438.2006.00777.x.
2
Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.明显早期上皮性卵巢癌淋巴结转移的危险因素:对手术分期的影响。
Gynecol Oncol. 2011 Sep;122(3):536-40. doi: 10.1016/j.ygyno.2011.05.001. Epub 2011 Jun 1.
3
Clinical significance of ascites in epithelial ovarian cancer.上皮性卵巢癌腹水的临床意义。
Neoplasma. 2013;60(5):546-52. doi: 10.4149/neo_2013_071.
4
Metastatic lymph node number in epithelial ovarian carcinoma: does it have any clinical significance?上皮性卵巢癌中的转移淋巴结数量:它有临床意义吗?
Gynecol Oncol. 2008 Feb;108(2):428-32. doi: 10.1016/j.ygyno.2007.09.014.
5
Lung resistance-related protein (LRP) expression in malignant ascitic cells as a prognostic marker for advanced ovarian serous carcinoma.恶性腹腔积液细胞中肺耐药相关蛋白(LRP)的表达作为晚期卵巢浆液性癌的预后标志物。
Ann Surg Oncol. 2013 Sep;20(9):3059-65. doi: 10.1245/s10434-013-2878-9. Epub 2013 Mar 24.
6
A large-scale multi-institutional study evaluating prognostic aspects of positive ascites cytology and effects of therapeutic interventions in epithelial ovarian cancer.一项评估上皮性卵巢癌阳性腹水细胞学预后方面和治疗干预效果的大规模多机构研究。
Sci Rep. 2021 Jul 26;11(1):15154. doi: 10.1038/s41598-021-93718-3.
7
The impact of pelvic retroperitoneal invasion and distant nodal metastases in epithelial ovarian cancer.盆腔腹膜后浸润和远处淋巴结转移对上皮性卵巢癌的影响。
Surg Oncol. 2014 Mar;23(1):40-4. doi: 10.1016/j.suronc.2013.10.005. Epub 2013 Oct 25.
8
Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: an NRG Oncology/GOG study.腹水可预测贝伐单抗在晚期上皮性卵巢癌、输卵管癌和腹膜癌一线治疗中的疗效:一项NRG肿瘤学/妇科肿瘤学组研究。
Gynecol Oncol. 2015 Oct;139(1):17-22. doi: 10.1016/j.ygyno.2015.07.103. Epub 2015 Jul 26.
9
Cytoreductive surgery for stage IV epithelial ovarian cancer.IV期上皮性卵巢癌的细胞减灭术。
J Exp Clin Cancer Res. 1999 Dec;18(4):449-54.
10
Intratumoral interleukin-6 predicts ascites formation in patients with epithelial ovarian cancer: A potential tool for close monitoring.肿瘤内白细胞介素-6可预测上皮性卵巢癌患者腹水形成:一种密切监测的潜在工具。
J Ovarian Res. 2015 Aug 19;8:58. doi: 10.1186/s13048-015-0183-x.

引用本文的文献

1
Morphometric analysis of neoplastic cell clusters in high-grade serous ovarian cancer ascites identifies a promising prognostic factor: a retrospective study.高级别浆液性卵巢癌腹水中肿瘤细胞簇的形态计量分析确定了一个有前景的预后因素:一项回顾性研究。
J Ovarian Res. 2025 Apr 8;18(1):74. doi: 10.1186/s13048-025-01653-y.
2
Overcoming the effects of fluid shear stress in ovarian cancer cell lines: Doxorubicin alone or photodynamic priming to target platinum resistance.克服卵巢癌细胞系中流体切应力的影响:多柔比星单独或光动力预处理以靶向铂耐药。
Photochem Photobiol. 2024 Nov-Dec;100(6):1676-1693. doi: 10.1111/php.13967. Epub 2024 Jun 7.
3
Effect of Intraperitoneal Chemotherapy with Regorafenib on IL-6 and TNF-α Levels and Peritoneal Cytology: Experimental Study in Rats with Colorectal Peritoneal Carcinomatosis.
瑞戈非尼腹腔化疗对白细胞介素-6和肿瘤坏死因子-α水平及腹膜细胞学的影响:结直肠癌腹膜转移大鼠的实验研究
J Clin Med. 2023 Nov 23;12(23):7267. doi: 10.3390/jcm12237267.
4
Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers.发展与展望:用于治疗妇科癌症的多功能核酸纳米药物。
Small. 2024 Oct;20(41):e2301776. doi: 10.1002/smll.202301776. Epub 2023 Jul 30.
5
The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination.腔道转移生态系统与上皮性卵巢癌扩散
Front Endocrinol (Lausanne). 2022 Apr 28;13:886533. doi: 10.3389/fendo.2022.886533. eCollection 2022.
6
Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response.卵巢癌中的恶性腹水:分子特征和治疗反应的细胞、无细胞及生物物理决定因素
Cancers (Basel). 2021 Aug 26;13(17):4318. doi: 10.3390/cancers13174318.
7
Flow-induced Shear Stress Confers Resistance to Carboplatin in an Adherent Three-Dimensional Model for Ovarian Cancer: A Role for EGFR-Targeted Photoimmunotherapy Informed by Physical Stress.在卵巢癌的三维贴壁模型中,流动诱导的剪切应力赋予对卡铂的抗性:物理应激对表皮生长因子受体靶向光免疫疗法的作用
J Clin Med. 2020 Mar 28;9(4):924. doi: 10.3390/jcm9040924.
8
Ascites Volumes and the Ovarian Cancer Microenvironment.腹水容量与卵巢癌微环境
Front Oncol. 2018 Dec 17;8:595. doi: 10.3389/fonc.2018.00595. eCollection 2018.
9
Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer.胆固醇激活恶性腹水癌细胞中的 LXRɑ/β 促进卵巢癌的化疗耐药性。
BMC Cancer. 2018 Dec 10;18(1):1232. doi: 10.1186/s12885-018-5152-5.
10
Modeling the effect of ascites-induced compression on ovarian cancer multicellular aggregates.模拟腹水诱导的压迫对卵巢癌细胞聚集体的影响。
Dis Model Mech. 2018 Sep 25;11(9):dmm034199. doi: 10.1242/dmm.034199.